Supporting the development of digital health , which will drive the medicine of tomorrow, is at the heart of the ICAN IHU’s strategy.
IHU ICAN strives to support manufacturers of innovative e-health solutions, helping them to meet the new clinical requirements introduced by European regulations 2017/745 for medical devices and 2017/746 for in vitro diagnostic medical devices.
ICAN supports e-health companies in the development of new innovative devices by drawing on a diverse range of services and collaboration:
- Targeted advice and expertise on preclinical and clinical strategy in the field of cardiometabolic and nutritional pathologies (NASH, heart failure, diabetes and chronic wounds, rare diseases, etc.).
- Identification of patient needs
- Advice on identifying patient needs, defining expected performance and the target population for the medical device
- Scientific and medical support in designing the clinical or performance evaluation plan
- Scientific and medical support in drafting clinical study protocols
- Carrying out clinical trials with a dedicated investigation platform with expertise in cardiometabolic diseases and nutrition
